BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Go back to BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

JPMorgan Reiterates Overweight Rating on BeiGene Ltd. (ONC), PT $311

March 3, 2025 4:19 PM EST

JPMorgan analyst Jessica Fye reiterated an Overweight rating and $311.00 price target on BeiGene Ltd. (NASDAQ: ONC)

The analyst comments "We hosted a call with mgmt and investors following ONCs strong 4Q print and 2025 guide. The conversation touched on the various factors associated with 2025... More

BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies

February 27, 2025 3:36 PM EST

Jefferies analyst Kelly Shi raised the price target on BeiGene Ltd. (NASDAQ: ONC) to $308.00 (from $286.00) while maintaining a Buy rating.

The analyst comments "ONC posted strong FY results, with $3.8B FY rev (+55% YoY, vs $3.7B cons). Despite investor discussion of script discrepancies, Brukinsa... More